Assessing seasonal influenza vaccine effectiveness
On 3 December 2015, ECDC hosts a technical meeting to discuss influenza vaccine effectiveness studies and how they can best meet public health needs as well as regulatory requirements.
Annual meeting of the European Influenza Surveillance Network, 2015
The ECDC annual meeting of the European Influenza Surveillance Network (EISN) prepared in collaboration with the EISN Coordination Committee, brought together epidemiological and virological surveillance contact points and representatives from reference laboratories from the 31 EU/EEA Member States as well as participants from EU pre-accession countries, Eastern European Neighbourhood Policy partner countries, the WHO Regional Office for Europe, and involved international institutions.
Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines
This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.
Joint ECDC-WHO/Europe Annual European Influenza Surveillance Meeting, 2016
The WHO Regional Office for Europe (WHO/Europe) and the European Centre for Disease Prevention and Control (ECDC) were jointly organising the annual influenza surveillance meeting.
Influenza vaccination of health care workers - can uptake be improved?
This online course was developed because seasonal influenza vaccination of health care workers (HCWs) is recommended in Europe but vaccination uptake remains low in most countries.
Differing patterns of influenza activity in the southern hemisphere during and between the 2009 pandemic and the 2010 winter influenza season – the usefulness for EuropeArchived
This is timely comparison carried out at the end of the 2010 southern hemisphere winter.
Are statins protective in patients with severe respiratory infections? Two new studies from EuropeArchived
In recent years there have been a series of arguments and findings suggesting that Statins (HMG-CoA reductase inhibitors) which used widely to lower cholesterol levels may also be important in reducing the risk associated with severe infective conditions.
Case inventory study from Sweden concerning association of Pandemrix vaccination and reports of narcolepsy with cataplexy in children and adolescentsArchived
ECDC has previously summarised information concerning the appearance of narcolepsy following the use of a specific pandemic vaccine (Pandemrix®) in children and adolescents in three European Countries.